Last updated: 2026-09-06 09:07:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Fennec Pharmaceuticals Inc. (FENC) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $12.37, with a market capitalization of $431.68M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.65 to $13.25. This page covers its latest market performance, valuation, price trends and company information.
$431.68M | |
$12.45 | |
$14.99 | |
$3.26 | |
$12.55 | |
182.66K | |
-- | |
-- | |
$13.25 | |
$5.65 | |
-- | |
-- |
Fennec Pharmaceuticals Inc. (FENC) last closed at $12.55 as of 2026-09-04 23:31:00, unchanged from the previous close of $12.55.
During the latest regular trading session, FENC traded between $3.26 and $14.99, with a volume of 182.66K shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Fennec Pharmaceuticals Inc. (FENC) moved from $12.29 to $12.37, representing a gain of 0.68% ($0.08).
The stock traded between $11.98 and $12.60 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 339.42 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 88.5%
FENC is currently trading at $12.37, placing it 88.5% of the way from its 52-week low of $5.65 to its 52-week high of $13.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 35 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Fennec Pharmaceuticals Inc. (FENC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.